Botulinum Toxin Type A - Haemagglutinin Complex — Drug Intelligence | 15 EU Trials

Filter these 15 trials by condition, phase, country and more.

Open in Search →

15 Registered trials

6 Recruiting

3 Completed trials

12 Sponsors

13 Countries

Phase III

Phase II

Phase IV

Phase I (FiH)

Phase III: 2 Phase II/III: 1 Phase II: 2 Phase III/IV: 1 Phase IV: 7 Phase I (FiH): 2

Sponsors using this IMP

Ipsen Innovation 4 Centre Hospitalier Universitaire De Nantes 2 Amsterdam UMC Stichting 1 Azienda Socio Sanitaria Territoriale Ovest Milanese 1 Frederiksberg Hospital 1 Gentofte Hospital 1 Hamburg University 1 Hospital Universitario de Burgos 1 Hospital Universitario La Paz 1 Ipsen Pharma 1 Radboud universitair medisch centrum Stichting 1 UZ Leuven 1

All trials

15 total

DIFFUSION CHARACTERISTICS OF LETIBOTULINUMTOXIN A IN COMPARISON TO ONA AND ABO-BONTA Pending

2024-511047-26-01 Phase IV 1 country Hamburg University
Head-to-head comparison of six different botox products voor glabellar frown wrinkles. Pending

2024-516865-35-01 Phase IV 1 country Stichting Amsterdam UMC
Evaluation of Botulinum TOXin type A in the treatment of Buerger’s disease Pending

2024-517772-38-00 Phase II/III 1 country Centre Hospitalier Universitaire De Toulouse
Upper-limb Active Function and Botulinum Toxin A Pending

2024-518147-37-00 Phase II 1 country Centre Hospitalier Universitaire De Toulouse
Treatment of Chronic Anal Fissure with Botulinum Toxin A Pending

2025-520748-13-01 Phase IV 1 country Hospital Universitario de Burgos
Clinical trial to evaluate the efficacy of early administration of botulinum toxin in open abdominal closure. Pending

2025-522410-23-00 Phase IV 1 country Hospital Universitario La Paz
PROBHE: Prehabilitation with Botulinum Toxin A in complex hernia: an Italian prospective study on predictive scores of myofascial release. Recruiting

2025-522451-25-00 Phase II 1 country Azienda Socio Sanitaria Territoriale Ovest Milanese
BoNT in stroke Recruiting

2024-513158-32-01 Phase III/IV 1 country UZ Leuven
Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study Recruiting

2024-519946-54-00 Phase IV 1 country Frederiksberg Hospital; Gentofte Hospital
Factors Determining the Efficacy of Botulinum Toxin for Arm Tremor in Dystonia: An Exploratory Study Recruiting

2024-515970-28-00 Phase IV 1 country Stichting Radboud universitair medisch centrum
A study to assess the safety and efficacy of IPN10200 in adult participants with moderate to severe upper facial lines Recruiting

2024-512782-14-00 Phase I (FiH) 2 countries Ipsen Innovation
A study investigating single injection of new botulinum toxin to determine safety and efficacy for treating spasticity in the upper limb Recruiting

2023-507202-14-00 Phase I (FiH) 10 countries Ipsen Innovation
A study to evaluate the effectiveness and safety of Dysport® for the prevention of chronic migraine in adults Ended

2023-504827-17-00 Phase III 5 countries Ipsen Innovation
A study to evaluate the effectiveness and safety of Dysport® for the prevention of episodic migraine in adults Ended

2023-504839-40-00 Phase III 5 countries Ipsen Innovation
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults with Upper Limb Spasticity Ended

2023-509196-16-00 Phase IV 1 country Ipsen Pharma

Showing 1–15 of 15 trials

← All drugs A–Z